TABLE 4.
Demographic characteristics of US cosmetic visits for dermal fillers and neurotoxins
| AVERAGE ANNUAL VISITS | PERCENT OF VISITS | ANNUAL VISIT RATE PER 100,000 PERSONS (95% CI) | P-VALUE* | |
|---|---|---|---|---|
| Dermal fillers | ||||
| Gender | ||||
| Female | 80,000 | 85.2 | 64 (53 - 74) | <0.0001 |
| Male | 10,000 | 14.8 | 12(0-27) | |
| Race | ||||
| Caucasian | 80,000 | 86.4 | 43 (36 - 50) | Ref |
| African American | 2,000 | 2.3 | 6(0-18) | <0.0001 |
| Other | 1,000 | 1.3 | 36 (0 - 74) | 0.27 |
| Neurotoxins | ||||
| Gender | ||||
| Female | 410,000 | 94.2 | 274 (206 - 343) | <0.0001 |
| Male | 30,000 | 5.8 | 18(5 - 30) | |
| Race | ||||
| Caucasian | 380,000 | 87.8 | 163(117 - 209) | Ref |
| African American | 1000 | 0.3 | 3(0-10) | <0.0001 |
*
Comparing males to females and Caucasians to Afican Americans or “other” races
†
Patient race was not identified at 10% of dermal filler visits and 9% of neurotoxin visits